SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Srinivasa Ramanujan

PatientSrinivasa Ramanujan
Date of birth1996-12-22
IdentifiersMRN HR-ET020-SYN; SSN (made up) 000-20-1937
Document date2026-02-23
AuthorEdmund Ashworth, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six weeks: recovery, final sputum cultures, liver tests before rifampin, vitamin B12, mood, influenza vaccine. [S]

History of Present Illness

Mr. Ramanujan returns six weeks after diagnosis. He finished paromomycin as planned and his stools returned to normal within two days. He has had no fever, the pain under his ribs has gone, and he has gained almost 3 kg. He is cooking twice a day now, with milk and curd daily, and takes his vitamin B12 and weekly vitamin D. He sees the counselor weekly, calls his family each Sunday, and has been to two community meals with families from the local Tamil association. The final sputum cultures from January show no growth at six weeks; Dr. Raghunathan reviewed them and the plan for latent infection by message. He is working full days again. [S]

ElementDetail
Abscess treatmentMetronidazole and paromomycin completed
Sputum culturesNo growth at six weeks
WeightUp nearly 3 kg
MoodPHQ-9 8

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or sweats; appetite good
GastrointestinalNegativeNo abdominal pain; stools normal
RespiratoryNegativeNo cough
NeurologicalNegativeNo numbness or tingling
PsychiatricPositiveMood better; still misses his family; no thoughts of self-harm

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metronidazole 250 mg oral tablet, three tablets (750 mg) three times a day with food for 10 daysThree tablets every 8 hours with food for 10 daysOral route2026-01-14 to 2026-01-23completedS
Paromomycin 250 mg oral capsule, two capsules (500 mg) three times a day with meals for 7 days, started the day after metronidazole endsTwo capsules every 8 hours with meals for 7 daysOral route2026-01-24 to 2026-01-30completedS
Vitamin B12 (cyanocobalamin) 1,000 microgram oral tablet, one tablet dailyOne tablet dailyOral route2026-01-14activeS
Cholecalciferol 50,000 unit (1.25 mg) oral tablet, one tablet once a week for 8 weeksOne tablet once a week for 8 weeksOral route2026-01-14 to 2026-03-04completedS
Rifampin 300 mg oral capsule, two capsules (600 mg) once daily on an empty stomach for 4 monthsTwo capsules each morning before breakfast for 4 monthsOral route2026-02-23activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-02-23Body height165cmS
2026-02-23Body weight54.8kgS
2026-02-23Body mass index (BMI) [Ratio]20.1kg/m2S
2026-02-23Systolic blood pressure116mm[Hg]S
2026-02-23Diastolic blood pressure72mm[Hg]S
2026-02-23Heart rate74/minS
2026-02-23Respiratory rate14/minS
2026-02-23Body temperature36.6CelS
2026-02-23Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-23Leukocytes [#/volume] in Blood by Automated count6.810*3/uL4-11 10*3/uLNormalS
2026-02-23Hemoglobin [Mass/volume] in Blood12.6g/dL13.2-17.1 g/dLLowS
2026-02-23MCV [Entitic mean volume] in Red Blood Cells by Automated count94fL80-100 fLNormalS
2026-02-23Platelets [#/volume] in Blood by Automated count29010*3/uL150-400 10*3/uLNormalS
2026-02-23C reactive protein [Mass/volume] in Serum or Plasma6mg/L<=5 mg/LHighS
2026-02-23Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma118U/L40-129 U/LNormalS
2026-02-23Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma28U/L7-41 U/LNormalS
2026-02-23Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L10-40 U/LNormalS
2026-02-23Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
2026-02-23Albumin [Mass/volume] in Serum or Plasma3.9g/dL3.5-5 g/dLNormalS
2026-02-23Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma410pg/mL232-1245 pg/mLNormalS
2026-02-23Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
2026-02-23Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]6{score}S

Physical Exam

Vital signs recorded on 2026-02-23; see the Vital Signs section. [S]

SystemFinding
GeneralWell; temperature 36.6 °C, pulse 74; weight 54.8 kg
RespiratoryClear, including the right base
AbdomenLiver not enlarged or tender
SkinNo jaundice

Problems

ProblemClinical statusVerificationCodeProvenance
Evening fevers to 38.6 °C with night sweats for about four weeksresolvedconfirmed R50.9S — Synthetic presenting symptom, superseded by the diagnosis at the second visit.
Weight loss of 5 kg over two months (57 to 52 kg), with poor appetiteresolvedconfirmed R63.4S — Synthetic presenting symptom, superseded by the diagnosis at the second visit.
Dull right upper quadrant pain for three weeks, worse on deep breathing and lying on the right side, with a tender liver edgeresolvedconfirmed R10.11S — Synthetic presenting symptom, superseded by the diagnosis at the second visit.
Amebic liver abscess: a single 6.2 x 5.4 cm abscess in the right lobe (segment VII) on ultrasound, Entamoeba histolytica antibody positive, blood cultures negative, years after two episodes of dysentery in India; treated with metronidazole and then paromomycin; synthetic modern diagnosis linked to the hepatic amoebiasis later proposed for his illnessactiveconfirmed A06.4S — Synthetic modern diagnosis; it does not settle the historical diagnostic conflict (CLM-0010, CLM-0011).
Vitamin B12 deficiency from a strict vegetarian diet (B12 168 pg/mL), with anemia (hemoglobin 11.2 g/dL, MCV 99 fL) to which inflammation also contributesactiveconfirmed D51.3S — Synthetic finding anchored to his documented diet and the vitamin deficiency later proposed.
Vitamin D deficiency (25-hydroxyvitamin D 9 ng/mL)activeconfirmed E55.9S — Synthetic finding anchored to his documented diet and the vitamin deficiency later proposed.
Positive interferon-gamma release assay, with chest radiograph and sputum smears and NAAT negative for tuberculosis; cultures pendingresolvedconfirmed R76.12S — Synthetic finding, superseded by the diagnosis of latent infection when cultures were negative.
Latent tuberculosis infection: positive interferon-gamma release assay, normal lungs on the radiograph, three sputum smears, NAAT and cultures negative; treated with four months of rifampinactiveconfirmed Z22.7S — Synthetic modern diagnosis; active tuberculosis was excluded, which does not settle the historical question.
Adjustment disorder with depressed mood (PHQ-9 12, no thoughts of self-harm) during a serious illness, far from his wife and familyactiveconfirmed F43.21S — Synthetic modern diagnosis anchored to his documented loneliness; not a claim about his real mental health.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationTemperature, symptoms and abdominal examination (liver tenderness, right lower rib tenderness)Every visitCompleted todayAfebrile; liver not tender
ExaminationWeight and BMIEvery visitCompleted today54.8 kg, up 2.8 kg since intake
LaboratoryBlood count and C-reactive proteinAt diagnosis, at the end of the tissue course, then until normalCompleted todayWhite cells 6.8, hemoglobin 12.6, MCV 94, platelets 290; CRP 6 mg/L
LaboratoryLiver tests (alkaline phosphatase, ALT, AST, bilirubin, albumin)At diagnosis, at the end of therapy, and before and during rifampinCompleted todayNormal, the baseline before rifampin
LaboratorySputum acid-fast smears, NAAT and mycobacterial culturesThree samples at baseline; cultures final at 6 to 8 weeksCompleted todayCultures no growth at six weeks; active tuberculosis excluded
Medication safetyAmebicide safety and completion (nausea, metallic taste, numbness on metronidazole; diarrhea on paromomycin; no overlap)At the start and every visit during treatmentCompleted todayBoth courses completed without lasting side effects
Medication safetyRifampin safety and adherence (nausea, rash, jaundice, missed doses, drug interactions)Monthly clinical check; liver tests at baseline and as indicatedCompleted todayStarted today; interactions reviewed; side effects explained
LaboratoryResponse to vitamin B12 replacementReticulocyte count at 1 week; blood count at about 8 weeks; neurologic examination at diagnosisCompleted todayHemoglobin 12.6 g/dL and B12 410 pg/mL; blood count again at three months
Self-managementDiet and weight plan within his vegetarian rulesEvery visitCompleted todayTwo meals a day; milk and curd daily
SurveyPHQ-9 and GAD-7At least monthly while symptoms are activeCompleted todayPHQ-9 8, GAD-7 6
SurveySuicide-risk review, safety plan and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; safety plan current
Self-managementSupport far from home (counseling, contact with family and community, department and fellowship)Every visitCompleted todayWeekly counseling, calls home and community meals
Medication safetyInfluenza vaccineEach seasonCompleted todayGiven today; deferred at intake because of fever
ReferralInfectious diseases reviewAt diagnosis; then at six weeks for the cultures and latent infectionCompleted todayDr. Raghunathan reviewed the cultures and agreed with rifampin by message

Goal progress:

Immunizations given today: Influenza vaccine, inactivated, this season [S]

Guideline basis: Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017); Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 (2020); DPDx: Amebiasis (laboratory diagnosis, including antibody detection in extraintestinal disease) (2026); A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis (2018); Position of the Academy of Nutrition and Dietetics: Vegetarian Diets (2016); CMID: Clinical Monitoring Intelligence Database, anemia and depression monographs (2026); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Adult Immunization Schedule by Age (2026)

Follow-up: Monthly clinical check on rifampin; preventive visit in about six weeks. Three-month review with blood count, liver tests, vitamins and mood. Call for jaundice, rash, vomiting, or fever. Next scheduled visit 2026-04-06: periodic adult preventive visit with pre-travel advice. [S]